"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 30 | 32 |
| 1997 | 1 | 35 | 36 |
| 1998 | 0 | 35 | 35 |
| 1999 | 0 | 39 | 39 |
| 2000 | 1 | 40 | 41 |
| 2001 | 1 | 26 | 27 |
| 2002 | 1 | 43 | 44 |
| 2003 | 2 | 36 | 38 |
| 2004 | 2 | 40 | 42 |
| 2005 | 3 | 31 | 34 |
| 2006 | 1 | 33 | 34 |
| 2007 | 3 | 41 | 44 |
| 2008 | 1 | 32 | 33 |
| 2009 | 5 | 33 | 38 |
| 2010 | 6 | 25 | 31 |
| 2011 | 1 | 32 | 33 |
| 2012 | 3 | 19 | 22 |
| 2013 | 1 | 37 | 38 |
| 2014 | 1 | 26 | 27 |
| 2015 | 1 | 32 | 33 |
| 2016 | 5 | 21 | 26 |
| 2017 | 2 | 29 | 31 |
| 2018 | 2 | 17 | 19 |
| 2019 | 2 | 15 | 17 |
| 2020 | 2 | 20 | 22 |
| 2021 | 2 | 14 | 16 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 2 | 3 |
| 2025 | 2 | 5 | 7 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Central Administration of Recombinant IGF1 Is Neuroprotective in a Rodent Model of Acute Liver Failure. Int J Mol Sci. 2026 Apr 16; 27(8).
-
Updates on Use and Monitoring of Direct Thrombin Inhibitors. Clin Lab Med. 2026 Jun; 46(2):259-277.
-
Whole-brain Mapping Reveals Diet-dependent Neuronal Activation and Selective Resistance to Exogenous FGF21. Endocrinology. 2025 Dec 05; 167(1).
-
Evaluation of a Novel Tc-24 Recombinant Antigen ELISA for Serologic Detection of Trypanosoma cruzi Infection in Dogs: A Pilot Study. Vet Med Sci. 2025 Sep; 11(5):e70570.
-
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiat Prot Dosimetry. 2025 Aug 26; 201(13-14):995-1005.
-
Dosing Reliability of Direct Thrombin Inhibitors in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis. ASAIO J. 2025 Sep 01; 71(9):691-700.
-
Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study. J Infect Dis. 2025 Jul 11; 231(6):e1114-e1118.
-
Bivalirudin Versus Heparin in Patients Undergoing Percutaneous Coronary Intervention in Acute Coronary Syndromes. Crit Pathw Cardiol. 2025 Mar 01; 24(1):e0372.
-
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study. Blood Adv. 2025 Jan 14; 9(1):66-77.
-
Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy. Blood Adv. 2024 07 23; 8(14):3718-3720.